A novel mechanism by which tissue transglutaminase activates signaling events that promote cell survival

Journal of Biological Chemistry

Volumn 289, Issue 14, 2014, Pages 10115-10125

  Boroughs, Lindsey K ^a   Antonyak, Marc A ^a   Cerione, Richard A ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL CULTURE; CELL DEATH; CHEMICAL ACTIVATION; DISEASES; ENZYMES; FIBROBLASTS; PROTEINS;

CANCER PROGRESSION; CHEMORESISTANCE; ECTOPIC EXPRESSIONS; MONODANSYLCADAVERINE; POTENTIAL TARGETS; SIGNALING EVENTS; TISSUE TRANS GLUTAMINASE (TTG); TISSUE TRANSGLUTAMINASE;

CELL SIGNALING;

EPIDERMAL GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTYROSINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE P60; S6 KINASE;

ANIMAL CELL; ANTIBODY DETECTION; APOPTOSIS; ARTICLE; BIOTINYLATION; CARCINOGENESIS; CELL DENSITY; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR DYNAMICS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

AKT; APOPTOSIS; CELL SURVIVAL; P70 S6-KINASE; PI3-KINASE (PI3K); SRC; TISSUE TRANSGLUTAMINASE; TRANSFORMATION;

ANIMALS; CADAVERINE; CELL SURVIVAL; CHROMONES; ENZYME INHIBITORS; FIBROBLASTS; GTP-BINDING PROTEINS; HUMANS; MICE; MORPHOLINES; MULTIPROTEIN COMPLEXES; NIH 3T3 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PYRIMIDINES; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SRC-FAMILY KINASES; TOR SERINE-THREONINE KINASES; TRANSGLUTAMINASES;

EID: 84898071562     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.464693     Document Type: Article

References (40)

1. Singh, U. S., Erickson, J. W., and Cerione, R. A. (1995) Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglu- taminase from rabbit liver nuclei. Biochemistry 34, 15863-15871
2. Nakaoka, H., Perez, D. M., Baek, K. J., Das, T., Husain, A., Misono, K., Im, M. J., and Graham, R. M. (1994) Gh: a GTP-binding protein with trans-glutaminase activity and receptor signaling function. Science 264, 1593-1596
3. Jaffe, A. B., and Hall, A. (2005) Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21, 247-269
4. Folk, J. E. (1980) Transglutaminases. Annu. Rev. Biochem. 49, 517-531
5. Greenberg, C. S., Birckbichler, P. J., and Rice, R. H. (1991) Transglutami-nases: multifunctional cross-linking enzymes that stabilize tissues. Faseb J 5, 3071-3077
6. Antonyak, M. A., Singh, U. S., Lee, D. A., Boehm, J. E., Combs, C., Zgola, M. M., Page, R. L., and Cerione, R. A. (2001) Effects of tissue transglutami-nase on retinoic acid-induced cellular differentiation and protection against apoptosis. J. Biol. Chem. 276, 33582-33587
7. Aeschlimann, D., Wetterwald, A., Fleisch, H., and Paulsson, M. (1993) Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J. Cell Biol. 120, 1461-1470
8. Mehta, K., and Lopez-Berestein, G. (1986) Expression of tissue transglu-taminase in cultured monocytic leukemia (THP-1) cells during differentiation. Cancer Res. 46, 1388-1394
9. Telci, D., and Griffin, M. (2006) Tissue transglutaminase (TG2)-a wound response enzyme. Front Biosci. 11, 867-882
10. Verderio, E. A., Johnson, T., and Griffin, M. (2004) Tissue transglutami-nase in normal and abnormal wound healing: review article. Amino Acids 26, 387-404
11. Yuan, L., Siegel, M., Choi, K., Khosla, C., Miller, C. R., Jackson, E. N., Piwnica-Worms, D., and Rich, K. M. (2007) Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene 26, 2563-2573
12. Kim, D. S., Park, S. S., Nam, B. H., Kim, I.H., and Kim, S. Y. (2006) Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation. Cancer Res. 66, 10936-10943
13. Hwang, J.Y., Mangala, L. S., Fok, J.Y., Lin, Y.G., Merritt, W. M., Spannuth, W. A., Nick, A. M., Fiterman, D. J., Vivas-Mejia, P. E., Deavers, M. T., Coleman, R. L., Lopez-Berestein, G., Mehta, K., and Sood, A. K. (2008) Clinical and biological significance of tissue transglutaminase in ovarian carcinoma. Cancer Res. 68, 5849-5858
14. Verma, A., Wang, H., Manavathi, B., Fok, J.Y., Mann, A. P., Kumar, R., and Mehta, K. (2006) Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res. 66, 10525-10533
15. Satpathy, M., Cao, L., Pincheira, R., Emerson, R., Bigsby, R., Nakshatri, H., and Matei, D. (2007) Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase. Cancer Res. 67, 7194-7202
16. Mangala, L. S., Fok, J. Y., Zorrilla-Calancha, I. R., Verma, A., and Mehta, K. (2007) Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 26, 2459-2470
17. Antonyak, M. A., Li, B., Regan, A. D., Feng, Q., Dusaban, S. S., and Cerione, R. A. (2009) Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion. J. Biol. Chem. 284, 17914-17925
18. Mann, A. P., Verma, A., Sethi, G., Manavathi, B., Wang, H., Fok, J. Y., Kunnumakkara, A. B., Kumar, R., Aggarwal, B. B., and Mehta, K. (2006) Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. Cancer Res. 66, 8788-8795
19. Zhang, R., Tremblay, T. L., McDermid, A., Thibault, P., and Stanimirovic, D. (2003) Identification of differentially expressed proteins in human glio-blastoma cell lines and tumors. Glia 42, 194-208
20. Li, B., Antonyak, M. A., Druso, J. E., Cheng, L., Nikitin, A. Y., and Cerione, R. A. (2010) EGF potentiated oncogenesis requires a tissue transglutami-nase-dependent signaling pathway leading to Src activation. Proc. Natl. Acad. Sci. U.S.A. 107, 1408-1413
21. Cao, L., Petrusca, D. N., Satpathy, M., Nakshatri, H., Petrache, I., and Matei, D. (2008) Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. Carcinogenesis 29, 1893-1900
22. Verma, A., Guha, S., Wang, H., Fok, J. Y., Koul, D., Abbruzzese, J., and Mehta, K. (2008) Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin Cancer Res. 14, 1997-2005
23. Wang, J. B., Erickson, J. W., Fuji, R., Ramachandran, S., Gao, P., Dinavahi, R., Wilson, K. F., Ambrosio, A. L., Dias, S. M., Dang, C. V., and Cerione, R. A. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18, 207-219
24. Khosravi-Far, R., White, M. A., Westwick, J. K., Solski, P. A., Chrza-nowska-Wodnicka, M., Van Aelst, L., Wigler, M. H., and Der, C. J. (1996) Oncogenic Ras activation of Raf/mitogen-activated protein kinase-inde-pendent pathways is sufficient to cause tumorigenic transformation. Mol. Cell. Biol. 16, 3923-3933
25. Magdalena, J., Millard, T. H., and Machesky, L. M. (2003) Microtubule involvement in NIH 3T3 Golgi and MTOC polarity establishment. J. Cell Sci. 116, 743-756
26. Antonyak, M. A., Li, B., Boroughs, L. K., Johnson, J. L., Druso, J. E., Bryant, K. L., Holowka, D. A., and Cerione, R. A. (2011) Cancer cell-derived mi-crovesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc. Natl. Acad. Sci. U.S.A. 108, 4852-4857
27. Boroughs, L. K., Antonyak, M. A., Johnson, J. L., and Cerione, R. A. (2011) A unique role for heat shock protein 70 and its binding partner tissue transglutaminase in cancer cell migration. J. Biol. Chem. 286, 37094-37107
28. Antonyak, M. A., McNeill, C. J., Wakshlag, J. J., Boehm, J. E., and Cerione, R. A. (2003) Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells. J. Biol. Chem. 278, 15859-15866
29. Leslie, N. R., Batty, I. H., Maccario, H., Davidson, L., and Downes, C. P. (2008) Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 27, 5464-5476
30. Tamguney, T., and Stokoe, D. (2007) New insights into PTEN. J. Cell Sci. 120, 4071-4079
31. Auger, K. R., Carpenter, C. L., Shoelson, S. E., Piwnica-Worms, H., and Cantley, L. C (1992) Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro. J. Biol. Chem. 267, 5408-5415
32. Liu, X., Marengere, L. E., Koch, C. A., and Pawson, T. (1993) The v-Src SH3 domain binds phosphatidylinositol 3'-kinase. Mol. Cell. Biol. 13, 5225-5232
33. Haefner, B., Baxter, R., Fincham, V. J., Downes, C. P., and Frame, M. C. (1995) Cooperation of Src homology domains in the regulated binding of phosphatidylinositol 3-kinase. A role for the Src homology 2 domain. J. Biol. Chem. 270, 7937-7943
34. von Willebrand, M., Williams, S., Saxena, M., Gilman, J., Tailor, P., Jascur, T., Amarante-Mendes, G. P., Green, D. R., and Mustelin, T. (1998) Modification of phosphatidylinositol 3-kinase SH2 domain binding properties by Abl-or Lck-mediated tyrosine phosphorylation at Tyr-688. J. Biol. Chem. 273, 3994-4000
35. Cuevas, B. D., Lu, Y., Mao, M., Zhang, J., LaPushin, R., Siminovitch, K., and Mills, G. B. (2001) Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J. Biol. Chem. 276, 27455-27461
36. Ling, L. E., Druker, B. J., Cantley, L. C, and Roberts, T. M. (1992) Transformation-defective mutants of polyomavirus middle T antigen associate with phosphatidylinositol 3-kinase (PI3-kinase) but are unable to maintain wild-type levels of PI3-kinase products in intact cells. J. Virol. 66, 1702-1708
37. Serunian, L. A., Auger, K. R., Roberts, T. M., and Cantley, L. C. (1990) Production of novel polyphosphoinositides in vivo is linked to cell transformation by polyomavirus middle T antigen. J. Virol. 64, 4718-4725
38. Martin, G. S. (2004) The road to Src. Oncogene 23, 7910-7917
39. Antonyak, M. A., Miller, A. M., Jansen, J. M., Boehm, J. E., Balkman, C. E., Wakshlag, J. J., Page, R. L., and Cerione, R. A. (2004) Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J. Biol. Chem. 279, 41461-41467
40. Zhang, J., Antonyak, M. A., Singh, G., and Cerione R. A. (2013) A mechanism for the upregulation of EGF receptor levels in glioblastoma. Cell Rep 3, 2008-2020